GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SciSparc Ltd (NAS:SPRC) » Definitions » Operating Cash Flow per Share

SPRC (SciSparc) Operating Cash Flow per Share : $-0.88 (TTM As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is SciSparc Operating Cash Flow per Share?

SciSparc's operating cash flow per share for the six months ended in Dec. 2024 was $-0.27. SciSparc's operating cash flow per share for the trailing twelve months (TTM) ended in Dec. 2024 was $-0.88.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 76.10% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 76.00% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was -25.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for SciSparc's Operating Cash Flow per Share or its related term are showing as below:

SPRC' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -1219.1   Med: 38.95   Max: 76.1
Current: 76.1

During the past 13 years, SciSparc's highest 3-Year average Operating Cash Flow per Share Growth Rate was 76.10% per year. The lowest was -1219.10% per year. And the median was 38.95% per year.

SPRC's 3-Year OCF Growth Rate is ranked better than
96.71% of 1217 companies
in the Biotechnology industry
Industry Median: 9.1 vs SPRC: 76.10

SciSparc Operating Cash Flow per Share Historical Data

The historical data trend for SciSparc's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SciSparc Operating Cash Flow per Share Chart

SciSparc Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Operating Cash Flow per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -430.70 -64.06 -44.98 -14.43 -0.88

SciSparc Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Operating Cash Flow per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -21.95 -12.20 -4.83 -0.61 -0.27

Competitive Comparison of SciSparc's Operating Cash Flow per Share

For the Biotechnology subindustry, SciSparc's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SciSparc's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, SciSparc's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where SciSparc's Price-to-Operating-Cash-Flow falls into.


;
;

SciSparc Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

SciSparc's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2024 is calculated as

Operating Cash Flow per Share (A: Dec. 2024 )=Cash Flow from Operations (A: Dec. 2024 )/Shares Outstanding (Diluted Average) (A: Dec. 2024 )
=-5.104/5.825
=-0.88

SciSparc's Operating Cash Flow per Share for the quarter that ended in Dec. 2024 is calculated as

Operating Cash Flow per Share (Q: Dec. 2024 )=Cash Flow from Operations (Q: Dec. 2024 )/Shares Outstanding (Diluted Average) (Q: Dec. 2024 )
=-2.907/10.828
=-0.27

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-0.88

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SciSparc Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of SciSparc's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


SciSparc Business Description

Industry
Traded in Other Exchanges
N/A
Address
20 Raul Wallenberg Street, Tower A, 2nd Floor, Tel Aviv, ISR, 6971916
SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.